Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Neural circuits mediating circulating interleukin-1β-evoked fever in the absence of prostaglandin E2 production.

Tytuł:
Neural circuits mediating circulating interleukin-1β-evoked fever in the absence of prostaglandin E2 production.
Autorzy:
Mota CMD; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
Madden CJ; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, United States. Electronic address: .
Źródło:
Brain, behavior, and immunity [Brain Behav Immun] 2022 Jul; Vol. 103, pp. 109-121. Date of Electronic Publication: 2022 Apr 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Publication: <2000- > : Amsterdam : Elsevier
Original Publication: San Diego : Academic Press, [c1987-
MeSH Terms:
Dinoprostone*/metabolism
Fever*/chemically induced
Interleukin-1beta*/blood
Interleukin-1beta*/pharmacology
Adipose Tissue, Brown/physiology ; Animals ; Hypothalamus/physiology ; Indomethacin ; Rats ; Rats, Sprague-Dawley ; Sympathetic Nervous System ; Thermogenesis
References:
JAMA. 2006 Jul 5;296(1):87-93. (PMID: 16820551)
Nature. 1998 Sep 17;395(6699):281-4. (PMID: 9751056)
Circulation. 2010 Jun 22;121(24):2654-60. (PMID: 20530000)
Biomed Sci Instrum. 1993;29:369-76. (PMID: 8329615)
Int J Cardiol. 2017 Dec 1;248:286-293. (PMID: 28826800)
Annu Rev Physiol. 2019 Feb 10;81:285-308. (PMID: 30256726)
Sci Rep. 2020 Oct 22;10(1):18072. (PMID: 33093475)
Pharmaceuticals (Basel). 2019 Jun 29;12(3):. (PMID: 31261947)
Brain Res. 1996 Sep 16;733(2):263-72. (PMID: 8891309)
Neuroscience. 2003;122(1):5-15. (PMID: 14596844)
Temperature (Austin). 2015 Jul 28;2(3):392-405. (PMID: 27227053)
PLoS Biol. 2006 Sep;4(9):e284. (PMID: 16933973)
J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):136-40. (PMID: 8318499)
Br J Pharmacol. 2009 Sep;158(1):259-66. (PMID: 19422394)
Mediators Inflamm. 1994;3(5):365-73. (PMID: 18475582)
Neuroscientist. 2018 Aug;24(4):381-399. (PMID: 29557255)
Brain Behav Immun. 2017 Mar;61:236-243. (PMID: 27940259)
J Auton Nerv Syst. 1997 Jan 12;62(1-2):72-8. (PMID: 9021652)
J Neurosci. 2014 Aug 27;34(35):11684-90. (PMID: 25164664)
Oxid Med Cell Longev. 2014;2014:851692. (PMID: 25147596)
Neurosci Lett. 1993 Nov 26;163(1):41-4. (PMID: 8295729)
Am J Physiol. 1998 Nov;275(5):R1450-4. (PMID: 9791060)
Am J Physiol Regul Integr Comp Physiol. 2004 Feb;286(2):R320-5. (PMID: 14563660)
Brain Res. 1988 Apr 19;446(2):245-50. (PMID: 3259449)
Am J Physiol. 1988 Jul;255(1 Pt 2):R73-81. (PMID: 3260755)
J Comp Neurol. 2004 Apr 19;472(1):113-29. (PMID: 15024756)
J Neurosci. 2000 Nov 1;20(21):8153-9. (PMID: 11050138)
J Auton Nerv Syst. 1996 Dec 14;61(3):287-91. (PMID: 8988487)
J Neurosurg. 1986 Nov;65(5):686-92. (PMID: 3772457)
J Neuroimmunol. 1993 Apr;44(1):49-56. (PMID: 7684399)
Neuroscience. 2006 Sep 15;141(4):1685-95. (PMID: 16777343)
Neuroscience. 1998 Mar;83(1):281-93. (PMID: 9466417)
Postgrad Med. 2019 Mar;131(2):109-116. (PMID: 30575425)
Am J Physiol. 1988 Oct;255(4 Pt 2):R527-33. (PMID: 3263055)
J Neurosci. 2007 Sep 26;27(39):10476-86. (PMID: 17898219)
Exp Neurol. 1993 Apr;120(2):245-63. (PMID: 8491281)
Pharmacol Biochem Behav. 1991 Jun;39(2):535-9. (PMID: 1946595)
Auton Neurosci. 2022 Jan;237:102918. (PMID: 34823147)
Signal Transduct Target Ther. 2021 Feb 26;6(1):94. (PMID: 33637672)
Brain Res. 1999 Oct 9;844(1-2):157-63. (PMID: 10536272)
Curr Biol. 2018 Jul 23;28(14):2291-2301.e5. (PMID: 30017482)
Cells. 2021 Apr 20;10(4):. (PMID: 33924019)
J Basic Clin Physiol Pharmacol. 2017 Nov 27;28(6):555-562. (PMID: 28981444)
Cell Metab. 2014 Aug 5;20(2):346-58. (PMID: 24981837)
PLoS One. 2013;8(4):e60625. (PMID: 23577136)
J Neurosci. 1998 Nov 15;18(22):9471-9. (PMID: 9801384)
Exp Ther Med. 2016 Nov;12(5):3425-3432. (PMID: 27882174)
Mol Psychiatry. 2000 Nov;5(6):604-15. (PMID: 11126391)
Pharmacol Rev. 2018 Apr;70(2):278-314. (PMID: 29496890)
Am J Physiol Regul Integr Comp Physiol. 2008 Feb;294(2):R411-20. (PMID: 18032464)
Neuroscience. 2009 Jun 30;161(2):614-20. (PMID: 19327390)
Biol Pharm Bull. 1997 Apr;20(4):438-42. (PMID: 9145226)
Am J Physiol. 1989 Jan;256(1 Pt 1):E7-11. (PMID: 2783533)
Eur J Neurosci. 2011 Nov;34(9):1442-52. (PMID: 21978215)
Inflamm Res. 2002 Jan;51(1):24-32. (PMID: 11852909)
Br J Pharmacol. 2020 Nov;177(21):4813-4824. (PMID: 32329520)
J Pharmacol Exp Ther. 1991 Dec;259(3):988-96. (PMID: 1762091)
Allergy. 2020 Mar;75(3):561-575. (PMID: 31469167)
Am J Physiol Regul Integr Comp Physiol. 2001 Apr;280(4):R929-34. (PMID: 11247812)
Am J Physiol. 1998 Aug;275(2):E207-12. (PMID: 9688620)
Science. 2020 Mar 27;367(6485):1434. (PMID: 32198292)
Brain Res. 1991 Feb 1;540(1-2):217-23. (PMID: 2054614)
Surg Infect (Larchmt). 2005 Winter;6(4):369-75. (PMID: 16433601)
Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R671-7. (PMID: 15539607)
Br J Pharmacol. 1995 Mar;114(6):1171-8. (PMID: 7542531)
Br J Pharmacol. 2009 Apr;156(7):1115-23. (PMID: 19298391)
J Appl Physiol (1985). 2000 May;88(5):1607-13. (PMID: 10797120)
Stem Cells. 2013 Oct;31(10):2042-6. (PMID: 23681848)
J Neurosci. 1998 Aug 15;18(16):6279-89. (PMID: 9698320)
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R343-54. (PMID: 18463193)
Inflamm Res. 2000 Dec;49(12):727-31. (PMID: 11211925)
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2904-8. (PMID: 16477014)
J Neurosci. 2020 Mar 18;40(12):2573-2588. (PMID: 32079648)
Nat Rev Drug Discov. 2012 Aug;11(8):633-52. (PMID: 22850787)
Am J Physiol Regul Integr Comp Physiol. 2005 Dec;289(6):R1746-55. (PMID: 16123230)
J Neurosci. 2002 Jul 1;22(13):5606-18. (PMID: 12097512)
Nat Med. 2009 Jan;15(1):42-9. (PMID: 19098906)
Mediators Inflamm. 2015;2015:941413. (PMID: 26417153)
Aust Crit Care. 1997 Dec;10(4):120-2. (PMID: 9708071)
J Neuroinflammation. 2017 Nov 09;14(1):219. (PMID: 29121947)
Expert Rev Clin Pharmacol. 2010 Nov;3(6):769-76. (PMID: 22111779)
J Comp Neurol. 1997 May 5;381(2):119-29. (PMID: 9130663)
Cytokine. 2000 Mar;12(3):229-32. (PMID: 10704249)
Br J Pharmacol. 2004 Jun;142(4):667-70. (PMID: 15159279)
Semin Immunol. 2013 Dec 15;25(6):469-84. (PMID: 24275598)
Handb Clin Neurol. 2018;157:565-597. (PMID: 30459026)
J Neurosci. 2001 Apr 15;21(8):2669-77. (PMID: 11306620)
Neuroimmunomodulation. 2000;8(3):148-53. (PMID: 11124581)
J Physiol. 1990 Sep;428:299-312. (PMID: 2231415)
Acta Physiol (Oxf). 2020 Mar;228(3):e13401. (PMID: 31599481)
Brain Res. 2005 Dec 20;1066(1-2):92-100. (PMID: 16360659)
Neurosci Lett. 2019 Mar 23;696:225-232. (PMID: 30586638)
J Comp Neurol. 1995 Oct 30;361(4):681-98. (PMID: 8576422)
Science. 2020 Mar 6;367(6482):1105-1112. (PMID: 32139538)
Neuroscience. 2016 Jan 28;313:23-35. (PMID: 26608124)
Handb Clin Neurol. 2018;156:305-316. (PMID: 30454597)
Inflamm Res. 2000 Sep;49(9):473-9. (PMID: 11071122)
Pflugers Arch. 1997 Apr;433(6):691-8. (PMID: 9049158)
J Immunol. 2006 Oct 15;177(8):5574-84. (PMID: 17015745)
Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R1107-15. (PMID: 15961539)
Brain Behav Immun. 2017 Feb;60:1-12. (PMID: 26995317)
BMC Musculoskelet Disord. 2007 Aug 03;8:73. (PMID: 17683540)
Grant Information:
R01 DK112198 United States DK NIDDK NIH HHS
Contributed Indexing:
Keywords: Cyclooxygenase; Cytokine; Fever; Inflammation; Sympathetic nervous system
Substance Nomenclature:
0 (Interleukin-1beta)
K7Q1JQR04M (Dinoprostone)
XXE1CET956 (Indomethacin)
Entry Date(s):
Date Created: 20220416 Date Completed: 20220531 Latest Revision: 20230703
Update Code:
20240105
PubMed Central ID:
PMC9524517
DOI:
10.1016/j.bbi.2022.04.008
PMID:
35429606
Czasopismo naukowe
Infectious diseases and inflammatory conditions recruit the immune system to mount an appropriate acute response that includes the production of cytokines. Cytokines evoke neurally-mediated responses to fight pathogens, such as the recruitment of thermoeffectors, thereby increasing body temperature and leading to fever. Studies suggest that the cytokine interleukin-1β (IL-1β) depends upon cyclooxygenase (COX)-mediated prostaglandin E 2 production for the induction of neural mechanisms to elicit fever. However, COX inhibitors do not eliminate IL-1β-induced fever, thus suggesting that COX-dependent and COX-independent mechanisms are recruited for increasing body temperature after peripheral administration of IL-1β. In the present study, we aimed to build a foundation for the neural circuit(s) controlling COX-independent, inflammatory fever by determining the involvement of brain areas that are critical for controlling the sympathetic outflow to brown adipose tissue (BAT) and the cutaneous vasculature. In anesthetized rats, pretreatment with indomethacin, a non-selective COX inhibitor, did not prevent BAT thermogenesis or cutaneous vasoconstriction (CVC) induced by intravenous IL-1β (2 µg/kg). BAT and cutaneous vasculature sympathetic premotor neurons in the rostral raphe pallidus area (rRPa) are required for IL-1β-evoked BAT thermogenesis and CVC, with or without pretreatment with indomethacin. Additionally, activation of glutamate receptors in the dorsomedial hypothalamus (DMH) is required for COX-independent, IL-1β-induced BAT thermogenesis. Therefore, our data suggests that COX-independent mechanisms elicit activation of neurons within the DMH and rRPa, which is sufficient to trigger and mount inflammatory fever. These data provide a foundation for elucidating the brain circuits responsible for COX-independent, IL-1β-elicited fevers.
(Copyright © 2022 Elsevier Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies